Acrivon Therapeutics Inc (ACRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 19,687 | 22,649 | 21,662 | 24,954 | 25,140 |
| Operating Income | -19,687 | -22,649 | -21,662 | -24,954 | -25,140 |
| Other Income | 1,453 | 1,643 | 1,982 | 2,123 | 2,699 |
| Pre-tax Income | -18,234 | -21,006 | -19,680 | -22,831 | -22,441 |
| Net Income Continuous | -18,234 | -21,006 | -19,680 | -22,831 | -22,441 |
| Net Income | $-18,234 | $-21,006 | $-19,680 | $-22,831 | $-22,441 |
| EPS Basic Total Ops | -0.47 | -0.55 | -0.51 | -0.54 | -0.59 |
| EPS Basic Continuous Ops | -0.47 | -0.55 | -0.51 | -0.55 | -0.59 |
| EPS Diluted Total Ops | -0.47 | -0.55 | -0.51 | -0.54 | -0.59 |
| EPS Diluted Continuous Ops | -0.47 | -0.55 | -0.51 | -0.55 | -0.59 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.55 | -0.51 | -0.60 | -0.59 |
| EBITDA(a) | $-19,372 | $-22,487 | $-21,711 | $-25,548 | $-26,093 |